Gregory L. Damhorst, MD, PhD
Recent Publications
Damhorst GL*, Fujita AW*, Fitts E, Szabo B, Bowers HB, Sabino C, Ahmed A, Wang E, Piantadosi A, McLendon K, Sullivan J, Greenleaf M, McCaslin D, Palmore M, Anderson AM, Aldred B, Gunthel C, Martin GS, Colasanti JA, Lam WA, Bassit L, Rao A, Sheth AN, Titanji BK. Multisite mpox infection and viral dynamics among persons with HIV in metro-Atlanta. J Infect Dis. 2023 Nov 29:jiad530. doi: 10.1093/infdis/jiad530. PMID: 38019187.
Cheedarla N, Verkerke HP, Potlapalli S, McLendon KB, Patel A, Frank F, O'Sick WH, Cheedarla S, Baugh TJ, Damhorst GL, Wu H, Graciaa D, Hudaib F, Alter DN, Bryksin J, Ortlund EA, Guarner J, Auld S, Shah S, Lam W, Mattoon D, Johnson JM, Wilson DH, Dhodapkar MV, Stowell SR, Neish AS, Roback JD. Rapid, high throughput, automated detection of SARS-CoV-2 neutralizing antibodies against Wuhan-WT, delta and omicron BA1, BA2 spike trimers. iScience. 2023 Oct 18;26(11):108256. doi: 10.1016/j.isci.2023.108256. PMID: 37965140; PMCID: PMC10641509.
Lancelot M, Fibben K, Sullivan J, O'Sick W, McLendon K, Wu H, Rao A, Bassit LC, Greenleaf M, Miller P, Krull W, Tyburski E, Roback JD, Lam WA*, Damhorst GL*. Effect of swab pooling on the Accula point-of-care RT-PCR for SARS-CoV-2 detection. Front Microbiol. 2023 Aug 7;14:1219214. doi: 10.3389/fmicb.2023.1219214. PMID: 37608952; PMCID: PMC10440424.
Mermin-Bunnell K, Zhu Y, Hornback A, Damhorst G, Walker T, Robichaux C, Mathew L, Jaquemet N, Peters K, Johnson TM 2nd, Wang MD, Anderson B. Use of Natural Language Processing of Patient-Initiated Electronic Health Record Messages to Identify Patients With COVID-19 Infection. JAMA Netw Open. 2023 Jul 3;6(7):e2322299. doi: 10.1001/jamanetworkopen.2023.22299. PMID: 37418261; PMCID: PMC10329205.
Damhorst GL, Schoof N, Nguyen PV, Verkerke H, Wilber E, McLendon K, O'Sick W, Baugh T, Cheedarla S, Cheedarla N, Stittleburg V, Fitts EC, Neja MA, Babiker A, Piantadosi A, Roback JD, Waggoner JJ, Mavigner M, Lam WA. Investigation of blood plasma viral nucleocapsid antigen as a marker of active SARS-CoV-2 Omicron variant infection, Open Forum Infect Dis. 2023 May 2;10(5):ofad226. doi: 10.1093/ofid/ofad226. PMID: 37213426; PMCID: PMC10199120.
Greenleaf MN, Nehl E, Damhorst GL, Lam WA. Pivot, persevere, or perish: how Ellume Health overcame development and regulatory obstacles to become the first authorized over-the-counter COVID-19 test in the United States. Lab Chip. 2023 May 2. doi: 10.1039/d3lc00118k. Epub ahead of print. PMID: 37129954.
Damhorst GL, Verkerke HP, Harrington KRV, McLendon K, Lu A, Perez MA, Hussaini L, Anderson EJ, Stowell SR, Roback JD, Lam WA, Rostad CA. SARS-CoV-2 Antigenemia is Associated With Pneumonia in Children But Lacks Sensitivity to Diagnose Acute Infection. Pediatr Infect Dis J. 2023 Feb 1;42(2):130-135. doi: 10.1097/INF.0000000000003779. Epub 2022 Jan 11. PMID: 36638399; PMCID: PMC9838602.
Wilber E, Piantadosi A, Babiker A, McLendon K, O'Sick W, Fitts E, Webster AS, Verkerke H, Kim JS, Phadke VK, Rouphael N, Titanji BK, Blake WT, Howard-Anderson J, Roback JD, Lam WA*, Damhorst GL*. Nucleocapsid Antigenemia in Patients Receiving Anti-CD20 Therapy With Protracted COVID-19. Open Forum Infect Dis. 2022 Aug 17;9(8):ofac419. doi: 10.1093/ofid/ofac419. PMID: 36043176; PMCID: PMC9416058.
Verkerke HP*, Damhorst GL*, Graciaa DS, McLendon K, O'Sick W, Robichaux C, Cheedarla N, Potlapalli S, Wu SC, Harrington KRV, Webster A, Kraft C, Rostad CA, Waggoner JJ, Gandhi NR, Guarner J, Auld SC, Neish A, Roback JD, Lam WA, Shah NS, Stowell SR. Nucleocapsid Antigenemia Is a Marker of Acute SARS-CoV-2 Infection. J Infect Dis. 2022 Jul 25:jiac225. doi: 10.1093/infdis/jiac225. Epub ahead of print. PMID: 35877413.
Farmer S, Razin V, Peagler AF, Strickler S, Fain WB, Damhorst GL, Kempker RR, Pollock NR, Brand O, Seitter B, Heilman SS, Nehl EJ, Levy JM, Gottfried DS, Martin GS, Greenleaf M, Ku DN, Waggoner JJ, Iffrig E, Mannino R, Wang YF, Ortlund E, Sullivan J, Rebolledo PA, Clavería V, Roback JD, Benoit M, Stone C, Esper A, Frank F, Lam WA. Don't Forget About Human Factors: Lessons Learned from COVID-19 Point-of-Care Testing. Cell Rep Methods. 2022 May 3:100222. doi: 10.1016/j.crmeth.2022.100222. Epub ahead of print. PMID: 35527805; PMCID: PMC9061138.
*Shared first/last author